Nanis Nikolaos P. 4
4 · Teladoc Health, Inc. · Filed Sep 4, 2024
Insider Transaction Report
Form 4
Nanis Nikolaos P.
Chief Technology Officer
Transactions
- Exercise/Conversion
Common Stock
2024-08-30+506→ 74,464 total - Exercise/Conversion
Common Stock
2024-08-30+894→ 75,358 total - Exercise/Conversion
Common Stock
2024-08-30+1,085→ 76,443 total - Sale
Common Stock
2024-09-03$7.16/sh−1,033$7,400→ 75,410 total - Exercise/Conversion
Restricted Stock Units
2024-08-30−506→ 1,012 total→ Common Stock (506 underlying) - Exercise/Conversion
Common Stock
2024-08-30+370→ 73,958 total - Exercise/Conversion
Restricted Stock Units
2024-08-30−894→ 2,684 total→ Common Stock (894 underlying) - Exercise/Conversion
Restricted Stock Units
2024-08-30−1,085→ 6,511 total→ Common Stock (1,085 underlying) - Exercise/Conversion
Performance Stock Units
2024-08-30−370→ 2,218 total→ Common Stock (370 underlying)
Footnotes (7)
- [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- [F4]The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F5]On March 1, 2022, the reporting person was granted 6,064 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F6]On June 1, 2022, the reporting person was granted 10,730 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F7]On March 3, 2023, the reporting person was granted 13,021 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.